Case Report: Prompt Response to Savolitinib in a Case of Advanced Gastric Cancer With Bone Marrow Invasion and MET Abnormalities

Gastric cancer is one of the most common malignant tumors and patients show a short survival, those combined with bone marrow invasion have a median survival of only 37 days. Here we reported the treatment of a 47-year-old male with advanced gastric cancer and complicated with bone marrow invasion a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wen, He, Liping, Su, Lei, Zheng, Zhousan, Ding, Meilin, Ye, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013970/
https://www.ncbi.nlm.nih.gov/pubmed/35444940
http://dx.doi.org/10.3389/fonc.2022.868654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013970/
https://www.ncbi.nlm.nih.gov/pubmed/35444940
http://dx.doi.org/10.3389/fonc.2022.868654

Ejemplares similares